FDA PMA
FDA Class 3
Approved
🇺🇸 United States
Defibrillator, Implantable, Dual-Chamber
PMA: P050023
·
Supplement: S165
·
Decision Mar 8, 2022
Classifications
1
FEI Numbers
6
Registration Numbers
6
Basic Information
- Device Name
- Defibrillator, Implantable, Dual-Chamber
- Trade Name
- Acticor 7 VR-T, Rivacor 7 VR-T, Rivacor 5 VR-T, Rivacor 3 VR-T, Acticor 7 VR-T DX, Rivacor 7 VR-T DX, Rivacor 5 VR-T DX,
- PMA Number
- P050023
- Supplement Number
- S165
- Device Class
- FDA Class 3
- Product Code
- MRM
- Generic Name
- DEFIBRILLATOR, IMPLANTABLE, DUAL-CHAMBER
- Medical Specialty
- Unknown
- Advisory Committee
- Cardiovascular
- Decision
- Approved
- Decision Code
- APPR
- Decision Date
- March 8, 2022
- Date Received
- December 8, 2021
- Supplement Type
- Real-Time Process
- Supplement Reason
- Change Design/Components/Specifications/Material
- Expedited Review
- N
Advisory Committee Statement
Approval for a change to the battery cathode separator material.
Classifications
This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| MRM | Defibrillator, Implantable, Dual-Chamber | FDA class 3 | Unknown |